Solution phase synthesis of beta-turn peptidomimetic cyclic salts

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11753441
APP PUB NO 20210300966A1
SERIAL NO

17337383

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to methods of preparing and crystallizing β-turn cyclic peptidomimetic salts of formula I:

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

  • MIMETOGEN PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bohlin, Martin Johanneshov, SE 31 606
Devin, Chantal Lingolsheim, FR 6 4
Rocchi, Sébastien Hoenheim, FR 4 2
Tian, Wei Sodertalje, SE 182 1358

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • C07K Class
  • 0 % this patent is cited more than
  • 2 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges525152501 - 10025050075010001250150017502000225025002750300032503500375040004250450047505000525055005750

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 12, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 12, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 12, 2035